$1.810
+0.547 (+30.22%)Zum Schluss
- Hoch
- 2.950
- Eröffnung
- 1.550
- Volumengewichteter Durchschnittskurs
- 2.09
- Volumen
- 41.86M
- Marktkap.
- —
- Tief
- 1.500
- Umsatz
- 87.34M
- EV/EBITDA, TTM
- 0.00
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market.
KI-Analyse of PomDoctor Ltd (POM)
HaltenPomDoctor Ltd is currently not a strong buy due to significant financial challenges, despite a recent price surge. The stock closed at 1.17, down 42.36% yesterday, and has a negative forward P/E ratio, indicating ongoing losses. The recent 5-day change of +85.21% suggests volatility, but the year-to-date change of -80.06% raises concerns about long-term stability. The main risk is the company's current ratio of 0.35, indicating potential liquidity issues.
Bewertungskennzahlen
Event-Zeitleiste
News
8.510-19PRnewswirePomdoctor Terminates ADR Program, Lists on Nasdaq
- 8.510-12PRnewswire
Pomdoctor Advances Predictive Healthcare Transformation
- 8.510-09PRnewswire
Pomdoctor Faces Nasdaq Delisting Risk Due to Low Share Price
- 7.509-30PRnewswire
Pomdoctor Advances AI Chronic Disease Management System
7.509-30NewsfilterPomdoctor Advances AI Chronic Disease Management System
POM FAQ – beantwortet von Alphio AI
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector.
PomDoctor Ltd is currently not a strong buy due to significant financial challenges, despite a recent price surge. The stock closed at 1.17, down 42.36% yesterday, and has a negative forward P/E ratio, indicating ongoing losses. The recent 5-day change of +85.21% suggests volatility, but the year-to-date change of -80.06% raises concerns about long-term stability. The main risk is the company's current ratio of 0.35, indicating potential liquidity issues.
Community
Mehr ↗Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.